AstraZeneca

Biotech

ADA: AZ’s oral GLP-1 shows ‘competitive efficacy’ in phase 2

With a pair of phase 2 readouts, AstraZeneca is positioning itself to potentially capture a portion of the oral GLP-1 market.

Eric Sagonowsky Jun 9, 2026 9:48am

Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

AstraZeneca adds FDA cell and gene veteran—Chutes & Ladders

Jun 5, 2026 8:30am

Berlin Germany Brandenburg Gate

Fierce Pharma

Lilly, Boehringer slash investment plans in Germany

Jun 3, 2026 3:10pm

ASCO

ASCO: BMS' bispecific ADC puts TROP2 drugs on notice

Jun 2, 2026 8:00am

success failure signposts

AstraZeneca, after phase 3 miss, posts data behind approval bid

May 29, 2026 10:15am

FDA delays ruling on AstraZeneca drug after negative adcomm vote

May 27, 2026 4:43am